You Searched For: D-(+)-Galactose

Catalog Number: (76234-784)

Supplier: Rockland Immunochemical

Description: The Anti-Glut2 antibody was designed, produced, and validated as part of the Joy Cappel Young Investigator Award (JCYIA). The glucose transporter GLUT2 is a transmembrane carrier protein that allows protein facilitated glucose movement across cell membranes. GLUT2 is expressed in the plasma membranes of the liver, intestine, renal tubular cells, pancreatic islet beta cells, as well as in the portal and hypothalamic areas. Due to its low affinity and high capacity, GLUT2 transports dietary sugars, glucose, galactose and fructose in high concentrations, displaying large bidirectional fluxes in and out of cells. In pancreatic beta cells, GLUT2 is essential for glucose-stimulated insulin secretion. GLUT2 expression is necessary for the physiological control of glucose-sensitive genes, and its inactivation in the liver leads to impaired glucose-stimulated insulin secretion. In the nervous system, GLUT2-dependent glucose sensing regulates feeding, thermoregulation and pancreatic islet cell mass and function, as well as sympathetic and parasympathetic activities. In humans, inactivating mutations in GLUT2 cause Fanconi–Bickel syndrome, which is characterized by hepatomegaly and kidney disease. Anti-Glut2 is ideal for researchers interested in studying glucose transport mediated by Glut2 protein in the fields of diabetes, obesity, metabolism, and neuroscience research.

Catalog Number: (ALG493781-1G)

Supplier: ALADDIN SCIENTIFIC

Description: Biochemical/physiological effects:β- Galactosidase acts on the ends of disaccharides, glycoconjugates and polysaccharides β- D-galactosyl. It can be used to mediate sugar transfer reactions, such as galactooligosaccharide (GOS) synthesis. ββ- Galactosidase can be used in glycobiology and biotechnology.β- Galactosidase cleaves lactose into monosaccharide components, glucose and galactose. It can also catalyze the transglycosylation of glucose to form isolactose, which acts as β- The inducer of galactosidase.β- Galactosidase (from Aspergillus oryzae) has been used for: ① in vitro nuclear magnetic resonance (NMR); ② As β- Galactosidase analysis standard, determination of cell related β- Galactosidase concentration;③ To modify the sugar residues on the surface of the mutant synovial cells to study the adhesion; ④ Lactase hydrolysis experiment; ⑤ Reverse phase (RP) adsorption experiment; ⑥ Whey lactose hydrolysisProduct characteristics:1. Temperature range: effective temperature range: 20 ℃ - 70 ℃Optimum temperature: 40-60 ℃2. PH range: effective PH range: 2.0-7.5Optimum PH range: 4.0-5.5Enzymology Committee No.: 3.2.1.23Principle: lactase can decompose β- A galactoside bond that produces glucose and galactose.Definition of enzyme activity: 1g lactase decomposes ONPG (o-nitrobenzene) every minute at PH 4.5 and 37 ℃ β- D-galactopyranoside) to produce 1umol ONP (o-nitrophenol), that is, one enzyme activity unit is expressed in u/g.

New Product

Catalog Number: (76234-786)

Supplier: Rockland Immunochemical

Description: The Anti-Glut2 antibody was designed, produced, and validated as part of the Joy Cappel Young Investigator Award (JCYIA). The glucose transporter GLUT2 is a transmembrane carrier protein that allows protein facilitated glucose movement across cell membranes. GLUT2 is expressed in the plasma membranes of the liver, intestine, renal tubular cells, pancreatic islet beta cells, as well as in the portal and hypothalamic areas. Due to its low affinity and high capacity, GLUT2 transports dietary sugars, glucose, galactose and fructose in high concentrations, displaying large bidirectional fluxes in and out of cells. In pancreatic beta cells, GLUT2 is essential for glucose-stimulated insulin secretion. GLUT2 expression is necessary for the physiological control of glucose-sensitive genes, and its inactivation in the liver leads to impaired glucose-stimulated insulin secretion. In the nervous system, GLUT2-dependent glucose sensing regulates feeding, thermoregulation and pancreatic islet cell mass and function, as well as sympathetic and parasympathetic activities. In humans, inactivating mutations in GLUT2 cause Fanconi–Bickel syndrome, which is characterized by hepatomegaly and kidney disease. Anti-Glut2 is ideal for researchers interested in studying glucose transport mediated by Glut2 protein in the fields of diabetes, obesity, metabolism, and neuroscience research.

Catalog Number: (76262-666)

Supplier: Rockland Immunochemical

Description: The Anti-Glut2 antibody was designed, produced, and validated as part of the Joy Cappel Young Investigator Award (JCYIA). The glucose transporter GLUT2 is a transmembrane carrier protein that allows protein facilitated glucose movement across cell membranes. GLUT2 is expressed in the plasma membranes of the liver, intestine, renal tubular cells, pancreatic islet beta cells, as well as in the portal and hypothalamic areas. Due to its low affinity and high capacity, GLUT2 transports dietary sugars, glucose, galactose and fructose in high concentrations, displaying large bidirectional fluxes in and out of cells. In pancreatic beta cells, GLUT2 is essential for glucose-stimulated insulin secretion. GLUT2 expression is necessary for the physiological control of glucose-sensitive genes, and its inactivation in the liver leads to impaired glucose-stimulated insulin secretion. In the nervous system, GLUT2-dependent glucose sensing regulates feeding, thermoregulation and pancreatic islet cell mass and function, as well as sympathetic and parasympathetic activities. In humans, inactivating mutations in GLUT2 cause Fanconi–Bickel syndrome, which is characterized by hepatomegaly and kidney disease. Anti-Glut2 is ideal for researchers interested in studying glucose transport mediated by Glut2 protein in the fields of diabetes, obesity, metabolism, and neuroscience research.

Catalog Number: (IC0210116625)

Supplier: MP Biomedicals

Description: β-NADP is a coenzyme necessary for the alcoholic fermentation of glucose and the oxidative dehydrogenation of other substances. It occurs widely in living tissue, especially in the liver. Nicotinic acid can be converted to nicotinamide in the body and, in this form, is found as a component of two oxidation-reduction coenzymes: nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). The nicotinamide portion of the coenzyme transfers hydrogens by alternating between oxidized quaternary nitrogen and a reduced tertiary nitrogen. NADP is an essential coenzyme for glucose-6-phosphate dehydrogenase which catalyzes the oxidation of glucose-6-phosphate to 6-phosphogluconic acid. This reaction initiates metabolism of glucose by a pathway other than the citric acid cycle. This route is known as the hexose phosphate shunt or phosphogluconate pathway. Other enzymes which utilize NADP as a coenzyme are: Alcohol dehydrogenase:NADP dependent; Aromatic ADH:NADP dependent; Ferredoxin-NADP reductase; L-Fucose dehydrogenase; Gabase; Galactose-1-phosphate uridyl transferase; Glucose dehydrogenase; L-Glutamic dehydrogenase; Glycerol dehydrogenase:NADP specific; Isocitric dehydrogenase; Malic enzymes; 5,10-Methylenetetrahydrofolate dehydrogenase; 6-Phosphogluconate dehydrogenase and Succinic semialdehyde dehydrogenase.

Catalog Number: (CH01449-5KG)

Supplier: CHEM-IMPEX INTERNATIONAL, INC

Description: D(+)-GALACTOSE 5KG

New Product

Catalog Number: (CH01449-1KG)

Supplier: CHEM-IMPEX INTERNATIONAL, INC

Description: D(+)-GALACTOSE 1KG

New Product

Catalog Number: (76262-664)

Supplier: Rockland Immunochemical

Description: The Anti-Glut2 antibody was designed, produced, and validated as part of the Joy Cappel Young Investigator Award (JCYIA). The glucose transporter GLUT2 is a transmembrane carrier protein that allows protein facilitated glucose movement across cell membranes. GLUT2 is expressed in the plasma membranes of the liver, intestine, renal tubular cells, pancreatic islet beta cells, as well as in the portal and hypothalamic areas. Due to its low affinity and high capacity, GLUT2 transports dietary sugars, glucose, galactose and fructose in high concentrations, displaying large bidirectional fluxes in and out of cells. In pancreatic beta cells, GLUT2 is essential for glucose-stimulated insulin secretion. GLUT2 expression is necessary for the physiological control of glucose-sensitive genes, and its inactivation in the liver leads to impaired glucose-stimulated insulin secretion. In the nervous system, GLUT2-dependent glucose sensing regulates feeding, thermoregulation and pancreatic islet cell mass and function, as well as sympathetic and parasympathetic activities. In humans, inactivating mutations in GLUT2 cause Fanconi–Bickel syndrome, which is characterized by hepatomegaly and kidney disease. Anti-Glut2 is ideal for researchers interested in studying glucose transport mediated by Glut2 protein in the fields of diabetes, obesity, metabolism, and neuroscience research.

Catalog Number: (80051-824)

Supplier: MilliporeSigma

Description: A-D-GALACTOSE-1-PHOSPH 100MG

Certificates

Catalog Number: (102655-654)

Supplier: American Radiolabeled Chemicals

Description: GALACTOSE D 6 3H(N) 1 MCI

Catalog Number: (102655-656)

Supplier: American Radiolabeled Chemicals

Description: GALACTOSE D 6 3H(N) 5 MCI

Catalog Number: (77888-631)

Supplier: AFG Bioscience

Description: 2-O-(Α-L-FUCOPYRANOSYL)-D-GALACTOSE 10MG

New Product

Catalog Number: (77888-934)

Supplier: AFG Bioscience

Description: 6-O-Β-D-GALACTOPYRANOSYL-D-GALACTOSE 5MG

New Product

Catalog Number: (CH22030-1KG)

Supplier: CHEM-IMPEX INTERNATIONAL, INC

Description: B-D-GALACTOSE PENTAACETA 1KG

New Product

Catalog Number: (CH22799-100G)

Supplier: Chem-Impex International

Description: B-D-GALACTOSE PENTAACETA 100G

New Product

Catalog Number: (102552-906)

Supplier: BioVendor

Description: Zymogen granule membrane protein 16 (ZG16) is a 16 kDa protein first identified by immunoscreening of a rat pancreatic cDNA expression library with a polyspecific antiserum raised against purified zymogen granule membranes (ZGM). ZG16 displays sequence homology especially in the carbohydrate recognition domain to the plant lectin jacalin, which recognizes terminal galactose attached to N-acetylgalactosamine by a β1–3 linkage. According to its sequence homology with this lectin, ZG16 was considered a secretory lectin ZG16. Sequence analyses uncovered that ZG16 is highly conserved amongst mammals but also appears in many other species. Rat ZG16 was found to be highly expressed in pancreas, colon, and duodenum, where the protein was localized in the zymogen granule of pancreas. The previous reports indicated that rat ZG16 took part in the formation of zymogen granule by mediating the digested enzymes to the zymogen granule membrane in pancreatic acinar cells. Human ZG16 was shown to be highly expressed in adult liver and moderately expressed in intestine (jejunum, ileum) and colon. Moreover, ZG16 is also weakly expressed in pedunculus cerebellaris but not in other brain’s regions. Owing to the specific expression pattern in human liver, ZG16 was evaluated in hepatocellular carcinoma (HCC), a common cancer worldwide (it was found that human ZG16 was significantly down-regulated in HCC). ZG16 protein took part also in several secretions of glycoproteins (the secretion of human ZG16 would be affected when the synthesis of glycans was inhibited with inhibitor or without glucose in cell culture).